Megafine Pharma (P) Ltd.

MEGAFINE offering Innovative & Integrated API solutions is USFDA, EU-GMP,Australia-TGA, Canada-HC, Korea-MFDS, Japan-PMDA & Mexico-COFEPRIS inspected manufacturer of high quality APIs & Intermediates to Innovators and Generic companies having 26 US-DMFs, 6 CEPs and 350+ global regulatory filings. To support its rapid growth, we have commissioned a NEW API plant with five production blocks at our Vapi site. RECENTLY VALIDATED: Apremilast, Edoxaban, Cariprazine, Teriflunomide, Vortioxetine. NEW DEVELOPMENT: Vibegron .....